Weber said lead issues at MPS schools aren't going away, noting a lot of buildings have not been maintained and have chipping ...

Data from the first patients enrolled into Regenxbio's trial of its gene therapy for rare inherited disease mucopolysaccharidosis type I (MPS I) – also known as Hurler syndrome – has shown the ...

The market is poised for exponential growth with rising awareness, early diagnosis, and increasing investments in rare disease research. Mucopolysaccharidosis (MPS) is a group of rare genetic ...

Regenxbio closes strategic partnership with Nippon Shinyaku for MPS diseases: Rockville, Maryland Wednesday, March 5, 2025, 14:00 Hrs [IST] Regenxbio Inc., a leading clinical-stag ...

A primary growth driver for the Mepsevii market is the rising prevalence of mucopolysaccharidosis (MPS) disorders. These genetic conditions stem from enzyme deficiencies, preventing the proper ...

In the recent parliamentary debate, MPs voiced concerns about the rising rates of anxiety, depression, eating disorders and even suicide linked to excessive social media use among children.